Clinical Trial Update: PK, Safety, and Tolerability Study of RBP-7000 of Different Molecular Weight Polymer in Subjects With Schizophrenia [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the pharmacokinetics, safety, and tolerability of RBP-7000 with polymers of different molecular weights in individuals with schizophreni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• RBP-7000

Snippet

Sponsor: Indivior Inc. | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED